Our Solutions

e bulletin

E BULLETIN

  • E-Bulletin

    Diabetes — We’ve got Answers to your Questions

    Apr 1, 2015

    We are recognized for our expertise in complex trials, adaptive integrated designs and recruitment of special populations. To date, we have completed over 50 early stage trials involving anti-diabetic and hypoglycemic agents, including a single-center trial enrolling 75 Type I and Type II diabetic patients over four weeks.

  • E-Bulletin

    March 2015

    Mar 14, 2015

    Join us on March 24, for a mid-morning snack and an insightful presentation with Dr. Jonathan St-Germain, Senior Scientist Method Development, who will be presenting: Overcoming Challenges during Preclinical Sample Collection to Minimize the Impact on Toxicological Data.

    Sponsors now have an alternative solution to assess transdermal patch adhesion. Algorithme Pharma's proprietary tools, combined with ImageJ software, a public domain image processing program, have further improved the adhesion analysis process.

  • E-Bulletin

    A NOVEL APPROACH to Transdermal System Evaluation

    Mar 2, 2015

    Sponsors now have an alternative solution to assess transdermal patch adhesion. Algorithme Pharma's proprietary tools, combined with ImageJ software, a public domain image processing program, have further improved the adhesion analysis process.

  • E-Bulletin

    Take a virtual tour of our laboratories!

    Feb 2, 2015

    All you ever wanted to know about our labs and more!

  • E-Bulletin

    Large Molecule Quantification by Hybrid LBA/LCMS in a Regulated environment: Our Validation SOP

    Dec 2, 2014

    The use of LCMS detection for the bioanalysis of Large Molecules (LM) offers many advantages, including high specificity, wide linear dynamic range, fast method development, and the ability to quantify multiple proteins simultaneously.

  • E-Bulletin

    State-of-the-art Driving Simulator: testing the impairing effects of drugs

    Nov 1, 2014

    Since 2013, there has been a noticeable increase in the information provided by the Food and Drug Administration (FDA) on the effects of prescription and over-the-counter medication on driving, such as allergy medications and sleep drugs.

  • E-Bulletin

    Impaired Renal Function Clinical Trials – Early Phase Planning to Minimize Risks and Accelerate Drug Development

    Oct 1, 2014

    Algorithme Pharma presents a clinical trial case study in patients with impaired renal function to examine the impact of four renal impairment stage levels on an investigational drug’s pharmacokinetic and safety characteristics.

This site uses cookies to store information on your computer and improve your browsing experience. By remaining on this site, you consent to the placement of these cookies. Read our Cookie Policy to learn more.